This article is more than 5 years old. Information may no longer be current.

Levofloxacin controls pediatric bacterial conjunctivitis: study

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

A 0.5% formulation of levofloxacin controlled bacterial conjunctivitis in pediatric patients, according to a subset analysis of two studies.

Steven Lichtenstein, MD, and colleagues in the Levofloxacin Bacterial Conjunctivitis Study Group analyzed a subset of 167 pediatric patients from two randomized, masked, controlled parallel group studies. Patients in the subset ranged in age from 1 to 16. Drops were instilled every 2 hours on days 1 and 2 and every 4 hours on days 3 through 5.

At the endpoint, 0.5% levofloxacin eradicated more microbes than either 0.3% ofloxacin or placebo. This was statistically significant in children aged 2 to 11, according to the study authors.

The study is published in the October issue of the Journal of AAPOS.